Ayrton Drugs

Ayrton Drug Manufacturing Limited was a Ghanaian pharmaceutical company. It was established on September 24, 1965. The business entity was listed on the stock index of the Ghana Stock Exchange, the GSE All-Share Index. The factory it ran is based in Tesano, a suburb of Accra. The company's product portfolio included anti-hypertensives, hematinics, dermatological preparations, antibiotics, dewormers, pain killers and anti-inflammatory drugs. In February 2010 Adcock Ingram, a South African pharmaceutical company acquired 66% shares in the company.^[1]

Ayrton Drug Manufacturing Limited

Traded as	GSE: AYRTN
Industry	Pharmaceuticals
Founded	September 24, 1965
Headquarters	Accra, Greater Accra, Ghana
Key people	Chairman- Nik Amarteifio, CEO- Daniel Apeagyei Kissi
Products	Teedar, Samalin Cough syrup, Virol blood tonic, Ayrton Para caplets
Website	https://ayrtondrug.com (archived)

In January 2020, Ayrton Drug Manufacturing Limited and two other domestic pharmaceutical companies, Dannex Limited and Starwin Products Limited, had already merged and listed on the GSE as DAS Pharma.^[2]